SG11202005745VA - Neurotoxins for use in minimizing scarring - Google Patents

Neurotoxins for use in minimizing scarring

Info

Publication number
SG11202005745VA
SG11202005745VA SG11202005745VA SG11202005745VA SG11202005745VA SG 11202005745V A SG11202005745V A SG 11202005745VA SG 11202005745V A SG11202005745V A SG 11202005745VA SG 11202005745V A SG11202005745V A SG 11202005745VA SG 11202005745V A SG11202005745V A SG 11202005745VA
Authority
SG
Singapore
Prior art keywords
neurotoxins
minimizing scarring
scarring
minimizing
Prior art date
Application number
SG11202005745VA
Other languages
English (en)
Inventor
Sawsan Abushakra
Wajdie Ahmad
Fauad Hasan
Michael Jarpe
Original Assignee
Bonti Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bonti Inc filed Critical Bonti Inc
Publication of SG11202005745VA publication Critical patent/SG11202005745VA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A61K38/4893—Botulinum neurotoxin (3.4.24.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24—Metalloendopeptidases (3.4.24)
    • C12Y304/24069—Bontoxilysin (3.4.24.69), i.e. botulinum neurotoxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Birds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11202005745VA 2017-12-18 2018-12-19 Neurotoxins for use in minimizing scarring SG11202005745VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762599972P 2017-12-18 2017-12-18
PCT/US2018/066499 WO2019126322A1 (fr) 2017-12-18 2018-12-19 Neurotoxines destinées à être utilisées pour réduire au minimum la formation de cicatrices

Publications (1)

Publication Number Publication Date
SG11202005745VA true SG11202005745VA (en) 2020-07-29

Family

ID=65441036

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202005745VA SG11202005745VA (en) 2017-12-18 2018-12-19 Neurotoxins for use in minimizing scarring

Country Status (14)

Country Link
US (2) US20190183987A1 (fr)
EP (1) EP3727430A1 (fr)
JP (2) JP2021506985A (fr)
KR (1) KR20210093748A (fr)
CN (1) CN111712253A (fr)
AU (1) AU2018388588A1 (fr)
BR (1) BR112020012466A2 (fr)
CA (1) CA3086160A1 (fr)
CL (1) CL2020001639A1 (fr)
IL (1) IL275451A (fr)
MX (1) MX2020006391A (fr)
RU (1) RU2020121973A (fr)
SG (1) SG11202005745VA (fr)
WO (1) WO2019126322A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3057302A1 (fr) * 2017-03-22 2018-09-27 Bonti, Inc. Neurotoxines botuliques pour utilisation en therapie
GB201815844D0 (en) * 2018-09-28 2018-11-14 Ipsen Biopharm Ltd Therapeutic & comestic uses of botulinum neurotoxin serotype e

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9914891A (pt) * 1998-10-27 2001-07-17 Mayo Foundation Processos para aperfeiçoamento de cura de ferimento
CA2580122A1 (fr) * 2004-09-27 2006-04-06 Merz Pharma Gmbh & Co. Kgaa Neurotoxines clostridiennes favorisant la cicatrisation de tissus
AU2012276512B2 (en) * 2011-06-27 2016-04-21 Sang Duck Kim Pharmaceutical composition for treating scars on the skin, and method for treating scars on the skin using same
US10076558B2 (en) * 2014-02-18 2018-09-18 Rnw Skn, Llc Prophylactic normalization of cutaneous wound repair
CA3057302A1 (fr) * 2017-03-22 2018-09-27 Bonti, Inc. Neurotoxines botuliques pour utilisation en therapie

Also Published As

Publication number Publication date
EP3727430A1 (fr) 2020-10-28
BR112020012466A2 (pt) 2020-11-24
KR20210093748A (ko) 2021-07-28
JP2021506985A (ja) 2021-02-22
CN111712253A (zh) 2020-09-25
WO2019126322A1 (fr) 2019-06-27
US20190183987A1 (en) 2019-06-20
CL2020001639A1 (es) 2020-12-04
RU2020121973A (ru) 2022-01-20
IL275451A (en) 2020-08-31
MX2020006391A (es) 2021-04-28
AU2018388588A1 (en) 2020-07-30
JP2024014923A (ja) 2024-02-01
CA3086160A1 (fr) 2019-06-27
US20220395561A1 (en) 2022-12-15

Similar Documents

Publication Publication Date Title
HUE047032T2 (hu) Szállítási blokk méret meghatározás
IL250520B (en) arrangement in mortar
GB201512044D0 (en) Application in German
GB201701371D0 (en) Title in german
GB201504655D0 (en) Title in German
HK1243041A1 (zh) 用於含二氧化碳的飲料的桶及其使用
GB201521190D0 (en) Application in german
GB201521206D0 (en) Title in german
IL275451A (en) Neurotoxins for use in reducing scarring
PL3380487T3 (pl) Systemy dodatków do stosowania w pegylacji białek
GB2579946B (en) Geoengineering constructions for use in railways
IL261286A (en) Connector suitable for use in jewlery
IL247998B (en) aptamer for fgf2 and used in it
GB201523035D0 (en) In terferometry
SG10201609308WA (en) Rotary switch suitable for use in adverse environmental conditions
GB201521191D0 (en) Application in german
IL240710A0 (en) Administration of sdf-1 to treat ischemic tissue
GB201512116D0 (en) Title in german
GB201516723D0 (en) Polypeptides for use in therapy
AU2015901835A0 (en) Improvement in linear accelarators
GB201415934D0 (en) Means for reversing desertification
GB201416493D0 (en) Polypeptides for use in therapy
GB201410705D0 (en) Anti-microbial agents and uses therefor
GB201400589D0 (en) Edwards loss in translation for use in assimilat